Median Technologies sets strategic review and R&D committees
Median Technologies says it has formed a Strategic Review Committee and an R&D Committee to unlock intrinsic value and accelerate its eyonis Pan-Cancer strategy.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.